INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,368,024 | -62.9% | 80,236 | -56.5% | 0.39% | -70.0% |
| Q4 2022 | $3,689,507 | -10.1% | 184,660 | -3.1% | 1.31% | -19.2% |
| Q3 2022 | $4,106,000 | -21.4% | 190,660 | -28.0% | 1.62% | -12.9% |
| Q2 2022 | $5,223,000 | -22.0% | 264,877 | -7.1% | 1.86% | -31.9% |
| Q1 2022 | $6,696,000 | +4.4% | 284,977 | +21.0% | 2.74% | -8.6% |
| Q4 2021 | $6,416,000 | -31.2% | 235,545 | -30.4% | 3.00% | -28.2% |
| Q3 2021 | $9,322,000 | -5.4% | 338,503 | -2.2% | 4.17% | -16.0% |
| Q2 2021 | $9,854,000 | -61.0% | 346,271 | -53.3% | 4.97% | -28.9% |
| Q1 2021 | $25,252,000 | +149.6% | 741,378 | +144.0% | 6.99% | -3.1% |
| Q4 2020 | $10,117,000 | -12.8% | 303,902 | -15.8% | 7.21% | -27.8% |
| Q3 2020 | $11,597,000 | +33.9% | 360,829 | +14.7% | 9.99% | +50.7% |
| Q2 2020 | $8,662,000 | +238.4% | 314,508 | +96.9% | 6.63% | +248.8% |
| Q1 2020 | $2,560,000 | +229.0% | 159,701 | +389.9% | 1.90% | +206.0% |
| Q4 2019 | $778,000 | – | 32,597 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |